Literature DB >> 1643710

Assessment of urea and other uremic markers for quantification of dialysis efficacy.

R C Vanholder1, R V De Smet, S M Ringoir.   

Abstract

To validate azotemic markers as an index for intradialytic changes in solute concentration, we compared eight solutes (pseudouridine, xanthine, hypoxanthine, peak 4, peak 5, p-hydroxyhippuric acid, indoxyl sulfate, and hippuric acid) with five classical azotemic markers (urea, creatinine, uric acid, phosphate, and potassium). We determined concentrations by reversed-phase HPLC coupled to ultraviolet absorption or photometrically. Seven compounds showed significant intercorrelation (P less than 10(-5)): urea, pseudouridine, uric acid, peaks 4 and 5, p-hydroxyhippuric acid, and creatinine. The hippuric acid concentration change after dialysis correlated with the change for these seven compounds and also with indoxyl sulfate, hypoxanthine, potassium, and the group of unidentified ultraviolet-absorbing HPLC peaks accumulating in uremia. We conclude that urea only partially represents the concentration changes of other retention compounds after dialysis; alternative markers, e.g., hippurate, should be considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643710

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  On-line monitoring of solutes in dialysate using wavelength-dependent absorption of ultraviolet radiation.

Authors:  I Fridolin; L G Lindberg
Journal:  Med Biol Eng Comput       Date:  2003-05       Impact factor: 2.602

2.  The 3-Year Incidence of Gout in Elderly Patients with CKD.

Authors:  Vivian S Tan; Amit X Garg; Eric McArthur; Ngan N Lam; Manish M Sood; Kyla L Naylor
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

3.  Staying on target with continuous dialysis.

Authors:  Sevag Demirjian; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-23       Impact factor: 8.237

4.  Plasma pseudouridine levels reflect body size in children on hemodialysis.

Authors:  Frank J O'Brien; Tammy L Sirich; Abigail Taussig; Enrica Fung; Lakshmi L Ganesan; Natalie S Plummer; Paul Brakeman; Scott M Sutherland; Timothy W Meyer
Journal:  Pediatr Nephrol       Date:  2019-11-14       Impact factor: 3.714

5.  Uric acid is the major determinant of absorbance in spent dialysate allowing spectrophotometric evaluation of dialysis dose.

Authors:  Carlo Donadio; Dario Calia; Silvia Ghimenti; Massimo Onor; Elisa Colombini; Roger Fuoco; Fabio Di Francesco
Journal:  J Nephrol       Date:  2013-12-07       Impact factor: 3.902

6.  Do only small uremic toxins, chromophores, contribute to the online dialysis dose monitoring by UV absorbance?

Authors:  Jürgen Arund; Risto Tanner; Fredrik Uhlin; Ivo Fridolin
Journal:  Toxins (Basel)       Date:  2012-10-18       Impact factor: 4.546

7.  A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis.

Authors:  Nida Zaidi; Mohammad Rehan Ajmal; Gulam Rabbani; Ejaz Ahmad; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.

Authors:  Renata P Assis; Juliana F A Castro; Vânia O Gutierres; Carlos A Arcaro; Renata S Brotto; Olga M M F Oliveira; Amanda M Baviera; Iguatemy L Brunetti
Journal:  BMC Nephrol       Date:  2015-04-11       Impact factor: 2.388

9.  The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.

Authors:  Cheng-Jui Lin; Tai-Cherng Liou; Chi-Feng Pan; Pei-Chen Wu; Fang-Ju Sun; Hsuan-Liang Liu; Han-Hsiang Chen; Chih-Jen Wu
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.

Authors:  Sunny Eloot; Daniel Schneditz; Tom Cornelis; Wim Van Biesen; Griet Glorieux; Annemie Dhondt; Jeroen Kooman; Raymond Vanholder
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.